| Izicelo | Isetyenziswa kwi-organic synthesis kunye ne-pharmaceutical intermediates | |
| Okoqobofi-orm | Ulwelo olungenambala ukuya kolutyheli | |
| Beka ubomi kwishelufa | Ngokwamava ethu, imveliso ingagcinwa iinyanga ezili-12 ukususela kumhla wokuziswa ukuba igcinwe kwizikhongozeli ezivalwe kakuhle, ikhuselwe ekukhanyeni nakubushushu kwaye igcinwe kumaqondo obushushu aphakathi kwama-5 ukuya kuma-30°C. | |
| Tiipropati eziqhelekileyo
| Indawo yokubila | 429.2±40.0 °C (Kuqikelelwe) |
| uxinano | 0.947±0.06 g/cm3 (Kuqikelelwe) | |
| i-pka | 8.68±0.20(Kuqikelelwe) | |
Amanyathelo okhuseleko
Xa uphatha le mveliso emva kokusebenzisa, landela iingcebiso nolwazi olukwiPhepha leDatha yoKhuseleko kwaye ulandele amanyathelo okhuseleko nococeko afunekayo ekuphatheni le khemikhali.
Amanyathelo okhuseleko
Ulwazi olukule nkcazelo yemveliso lusekelwe kulwazi lwethu lwangoku namava. Ngenxa yezinto ezininzi ezinokuchaphazela ukucutshungulwa nokusetyenziswa kwemveliso, olu lwazi alumkhululi umprosesa kwisidingo sokwenza uphando lwakhe kunye novavanyo, kwaye aluqinisekisi naluphi na ukufaneleka okuthile okanye ukufaneleka kwemveliso kuyo nayiphi na indlela ethile yokusetyenziswa. Zonke iinkcazo, imizobo, iifoto, idatha, ubungakanani, ubunzima, njl. eziqulethwe apha zinokutshintsha ngaphandle kwesaziso kwaye azibonisi umgangatho wesivumelwano semveliso ekuvunyelwene ngayo. Umgangatho wemveliso ekuvunyelwene ngawo ngokwesivumelwano uvela kuphela kwiingxelo ezikwinkcazo yemveliso. Luxanduva lomntu ofumana iimveliso zethu ukuqinisekisa ukuba nawaphi na amalungelo obunini bobuchwephesha kunye nemithetho nemigaqo ekhoyo iyathotyelwa.